Abbott Laboratories (NYSE:ABT) does about 5.88M shares in volume on a normal day but saw 10520053 shares change hands in Friday trading. The company now has a market cap of 186.15B USD. Its current market price is $107.28, marking an increase of 1.91% compared to the previous close of $105.27. The 52 week high reached by this stock is $121.64 whilst the lowest price level in 52 weeks is $89.67.
Abbott Laboratories (ABT) has a 20-day trading average at $110.36 and the current price is -11.81% off the 52-week high compared with 19.63% distance from its 52-week low. The 50-day simple moving average of the closing price is $114.14 and its 200-day simple moving average is $106.69. If we look at the stock’s price movements over the week, volatility stands at 2.58%, which decreases to 1.73% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 37.80 to suggest the stock is neutral.
The consensus objective for the share price is $126.73, suggesting that the stock has a potential upside of 15.35% over the period.
Morgan Stanley downgraded the stock to “Equal-Weight” from Overweight on May 30, 2023 at a price target of $112. Wolfe Research reiterated its price target at $107-$103.
Abbott Laboratories (ABT) stock is down -1.68% over the week and -3.78% over the past month. Its price is -2.53% year-to-date and -4.46% over the past year.
To reach the target analysts have set, the stock logically needs to grow 15.35 percent from here.
The company has a return on investment of 10.56% and return on equity of 15.15%. The price to earnings ratio (P/E ratio) amounts to 33.39 while the forward price to earnings ratio is 20.86. The beta has a value of 0.75. Price to book ratio is 4.82 and price to sales ratio is 4.62.
